诺诚健华（SH 688428，收盘价：20.35元）5月13日晚间发布公告称，2025年5月13日，公司的全资子公司北京诺诚健华医药科技有限公司与西湖大学签订《战略合作框架协议》与《科研合作协议》，双方将就创新药物研发、平台共建、人才培养及成果转化等方面建立合作。 2024年1至12月份，诺诚健华的营业收入构成为：医药制造业占比99.82%，其他业务占比0.18%。（文章来源：每日经济新闻）
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.